102 related articles for article (PubMed ID: 7506034)
41.
Sasaki H; Suzuki A; Shitara M; Hikosaka Y; Okuda K; Moriyama S; Yano M; Fujii Y
Biomed Rep; 2013 Jan; 1(1):93-96. PubMed ID: 24648901
[TBL] [Abstract][Full Text] [Related]
42. Preventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients.
Zhang L; Wang N; Zhou S; Ye W; Yao Q; Jing G; Zhang M
World J Surg Oncol; 2013 Apr; 11():84. PubMed ID: 23575450
[TBL] [Abstract][Full Text] [Related]
43. Examining T cells at vaccine sites of tumor-bearing hosts provides insights to dysfunctional T-cell immunity.
Barr KM; Jing W; Hallett WH; Gershan JA; Johnson BD
J Immunother; 2013 Jan; 36(1):41-51. PubMed ID: 23211619
[TBL] [Abstract][Full Text] [Related]
44. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.
Shah W; Yan X; Jing L; Zhou Y; Chen H; Wang Y
Cell Mol Immunol; 2011 Jan; 8(1):59-66. PubMed ID: 21200385
[TBL] [Abstract][Full Text] [Related]
45. Usage of cancer associated autoantibodies in the detection of disease.
Dudas SP; Chatterjee M; Tainsky MA
Cancer Biomark; 2010; 6(5-6):257-70. PubMed ID: 20938086
[TBL] [Abstract][Full Text] [Related]
46. Defective expression and modulation of B7-2/CD86 on B cells in B cell chronic lymphocytic leukemia.
Dai ZS; Chen QF; Lu HZ; Xie Y
Int J Hematol; 2009 Jun; 89(5):656-63. PubMed ID: 19430862
[TBL] [Abstract][Full Text] [Related]
47. A synergistic antitumor effect of interleukin-2 addition with CD80 immunogene therapy for peritoneal metastasis of gastric carcinoma.
Kosaka K; Yashiro M; Sakate Y; Hirakawa K
Dig Dis Sci; 2007 Aug; 52(8):1946-53. PubMed ID: 17404853
[TBL] [Abstract][Full Text] [Related]
48. Preoperative sorting of circulating T lymphocytes in patients with esophageal squamous cell carcinoma: its prognostic significance.
Nozoe T; Maehara Y; Sugimachi K
World J Gastroenterol; 2005 Nov; 11(42):6689-93. PubMed ID: 16425367
[TBL] [Abstract][Full Text] [Related]
49. CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression.
Schüle JM; Bergkvist L; Håkansson L; Gustafsson B; Håkansson A
J Transl Med; 2004 Dec; 2(1):45. PubMed ID: 15613231
[TBL] [Abstract][Full Text] [Related]
50. Costimulation-based immunotherapy for head and neck cancer.
Strome SE; Chen L
Curr Treat Options Oncol; 2004 Feb; 5(1):27-33. PubMed ID: 14697154
[TBL] [Abstract][Full Text] [Related]
51. Immunology of B7-H1 and its roles in human diseases.
Tamura H; Ogata K; Dong H; Chen L
Int J Hematol; 2003 Nov; 78(4):321-8. PubMed ID: 14686489
[TBL] [Abstract][Full Text] [Related]
52. Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.
Eguchi J; Hiroishi K; Ishii S; Mitamura K
Cancer Immunol Immunother; 2003 Jun; 52(6):378-86. PubMed ID: 12739068
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-1beta converting enzyme subfamily inhibitors prevent induction of CD86 molecules by butyrate through a CREB-dependent mechanism in HL60 cells.
Suzuki M; Shinohara F; Sato K; Taniguchi T; Takada H; Rikiishi H
Immunology; 2003 Mar; 108(3):375-83. PubMed ID: 12603604
[TBL] [Abstract][Full Text] [Related]
54. Decreased expression of intercellular adhesion molecule-1 (ICAM-1) and urokinase-type plasminogen activator receptor (uPAR) is associated with tumor cell spreading in vivo.
Donadio AC; Remedi MM; Frede S; Bonacci GR; Chiabrando GA; Pistoresi-Palencia MC
Clin Exp Metastasis; 2002; 19(5):437-44. PubMed ID: 12198772
[TBL] [Abstract][Full Text] [Related]
55. Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules.
Chapoval AI; Zhu G; Chen L
Mol Biotechnol; 2002 Jul; 21(3):259-64. PubMed ID: 12102550
[TBL] [Abstract][Full Text] [Related]
56. Expression of B7 costimulation molecules by colorectal cancer cells reducestumorigenicity and induces anti-tumor immunity.
Hu JY; Wang S; Zhu JG; Zhou GH; Sun QB
World J Gastroenterol; 1999 Apr; 5(2):147-151. PubMed ID: 11819415
[TBL] [Abstract][Full Text] [Related]
57. Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells.
Takenoyama M; Yoshino I; Eifuku R; So T; Imahayashi S; Sugaya M; Yasuda M; Inoue M; Ichiyoshi Y; Osaki T; Nagashima A; Nomoto K; Yasumoto K
Jpn J Cancer Res; 2001 Mar; 92(3):309-15. PubMed ID: 11267941
[TBL] [Abstract][Full Text] [Related]
58. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Roman JJ; Parham GP; Cannon MJ
J Virol; 2000 May; 74(10):4729-37. PubMed ID: 10775611
[TBL] [Abstract][Full Text] [Related]
60. The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.
Svane IM; Boesen M; Engel AM
Med Oncol; 1999 Dec; 16(4):223-38. PubMed ID: 10618685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
